Valle, Carmina G.
Heiling, Hillary M.
Deal, Allison M.
Diamond, Molly A.
Hales, Derek P.
Nezami, Brooke T.
Rini, Christine M.
Pinto, Bernardine M.
LaRose, Jessica Gokee
Tate, Deborah F.
Funding for this research was provided by:
National Cancer Institute, National Institutes of Health, United States (R01CA204965, R01CA204965, R01CA204965, R01CA204965, R01CA204965, R01CA204965, R01CA204965, R01CA204965)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056350)
National Center for Advancing Translational Sciences (UL1TR002489)
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill (University Cancer Research Fund)
Article History
Received: 23 January 2024
Accepted: 28 March 2024
First Online: 12 April 2024
Declarations
:
: All procedures were approved by the University of North Carolina at Chapel Hill Oncology Protocol Review Committee (LCCC1707) and Institutional Review Board (#16-3409) and performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: The authors have no relevant financial or non-financial interests to disclose.